Opendata, web and dolomites

FreeATPOC SIGNED

Towards an instrument-free future of molecular diagnostics at the point-of-care

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FreeATPOC project word cloud

Explore the words cloud of the FreeATPOC project. It provides you a very rough idea of what is the project "FreeATPOC" about.

time    lab    benefits    min    started    market    ing    big    latter    molecular    immuno    diagnostic    gaining    patient    regulated    point    heaters    tissues    instrument    smartphone    interestingly    sensitive    nucleic    ligases    plant    quantitative    infectious    poor    fastidiosa    adoption    advantage    xylella    failures    instruments    tools    slow    advantages    sophisticated    substantial    complexity    applicability       accompanied    acids    vision    extremely    restriction    demonstrated    predictive    genetic    temperature    primarily    final    enzymatically    divided    global    human    economic    acid    colorimetric    maintenance    sensitivities    poc    groups    assay    swabs    paper    monitoring    outbreaks    societal    diagnostics    simplicity    samples    technologies    care    combines    infrastructure    free    former    disease    enzymes    kits    influenza    generation    combined    electricity    translation    utility    newly    spreading    combination    takes    revolutionize    blood    hiv    models    expand    polymerases    resource    ambient    clinically    limited    pathogens    amplified    disadvantage    detection    enzymatic    ultra    uv    amplification    modules   

Project "FreeATPOC" data sheet

The following table provides information about the project.

Coordinator
IDRYMA TECHNOLOGIAS KAI EREVNAS 

Organization address
address: N PLASTIRA STR 100
city: IRAKLEIO
postcode: 70013
website: www.forth.gr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Greece [EL]
 Total cost 3˙052˙500 €
 EC max contribution 3˙052˙500 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IDRYMA TECHNOLOGIAS KAI EREVNAS EL (IRAKLEIO) coordinator 1˙146˙250.00
2    INSTITUT PASTEUR FR (PARIS CEDEX 15) participant 640˙000.00
3    GNOSIS DATA ANALYSIS IDIOTIKI KEFALAIOUCHIKI ETAIREIA EL (HERAKLION) participant 515˙000.00
4    UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST UK (LONDON) participant 401˙250.00
5    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) participant 350˙000.00

Map

 Project objective

Molecular diagnostics is still primarily a lab-based method. Emerging technologies for application at the point of care (POC) or need, i.e., where a patient or a sample is, have started gaining a big part of the molecular diagnostics market. Interestingly, available methods are divided in two groups: sophisticated instruments for ultra-sensitive temperature-regulated enzymatic amplification of nucleic acids and extremely simple paper-based immuno-diagnostic kits. Complexity, the main disadvantage of the former, results in their poor translation to several applications at the POC. Simplicity, often accompanied by failures, of the latter is the reason for their slow adoption even in resource limited areas. Our vision is an instrument-free approach that combines the advantages of both groups, i.e., a method that does not use heaters or modules that require electricity, infrastructure and maintenance, but, still, takes advantage of enzymatically-amplified nucleic acids detection. To achieve the above, novel diagnostic tools for genetic amplification based on ligases, polymerases and restriction enzymes operating at ambient temperature will be developed, combined with quantitative smartphone colorimetric/UV detection. The global applicability of the new approach will be demonstrated during infectious disease (Influenza and HIV) testing in human samples (blood and swabs) and plant pathogens (Xylella fastidiosa) in plant-tissues. In all cases, we aim for a time-to-result of less than 60 min, demonstrated sensitivities down to the clinically/field relevant values and a final cost in the order of $1 per assay. Combination of Free@POC concept with newly developed predictive models will expand its utility to monitoring disease outbreaks and their spreading. This new generation of instrument-free molecular diagnostics is expected to revolutionize nucleic acid analysis at the POC but also in applications beyond resulting in substantial societal as well as economic benefits.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FREEATPOC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FREEATPOC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

LABELFREE (2019)

LABEL FREE IMAGING WITH PHI-SCAT

Read More  

SHERO (2019)

Self-HEaling soft RObotics

Read More